The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Statins: mechanism of action and effects
Open accessAbstract
The beneficial effects of statins are the result of their capacity to reduce cholesterol biosyntesis, mainly in the liver, where they are selectively distributed, as well as to the modulation of lipid metabolism, derived from their effect of inhibition upon HMG‐CoA reductase. Statins have antiatherosclerotic effects, that positively correlate with the percent decrease in LDL cholesterol. In addition, they can exert antiatherosclerotic effects independently of their hypolipidemic action. Because the mevalonate metabolism generates a series of isoprenoids vital for different cellular functions, from cholesterol synthesis to the control of cell growth and differentiation, HMG‐CoA reductase inhibition has beneficial pleiotropic effects. Consequently, statins reduce significantly the incidence of coronary events, both in primary and secondary prevention, being the most efficient hypolipidemic compounds that have reduced the rate of mortality in coronary patients. Independent of their hypolipidemic properties, statins interfere with events involved in bone formation and impede tumor cell growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the Statin class of drugs inhibit 3-hydroxy-3-methylglutaryl (HMG) CoA reductase (HMGCR), the rate-limiting enzyme of de novo cholesterol synthesis5”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Statins (3-Hydroxy-3-methylglutaryl CoA reductase inhibitors) inhibit the endogenous synthesis of cholesterol by inhibiting the rate-limiting enzyme of the mevalonate pathway.(14)”
From Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis (2025) · cites this paper as [14]
In the citing paper
“Statins are competitive inhibitors of HMG-CoA reductase, which catalyses the conversion of HMG-CoA to mevalonate, a rate-limiting step in the isoprenoid biosynthetic pathway, which is involved in the synthesis of cholesterol in humans and ergosterol in fungi [10] .”
From Statins as antifungal agents (2011) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., Fata, V. L., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,837
Current Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,216
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P. L., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 957
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 573
Lennernäs, H., & Fager, G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732050-00005 · Cited by 527
Wagner, A. H., Köhler, T. C., Rueckschloss, U., Just, I., & Hecker, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.61 · Cited by 517
HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages
Bellosta, S., Via, D. P., Canavesi, M., Pfister, P., Fumagalli, R., Paoletti, R., & Bernini, F. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.11.1671 · Cited by 512
Research works printed but not linked: 2
- Voet D., 1995, Biochemistry, 315
- StancuC. NiculescuL. ToporanD. SimaA. IoanA. SimionescuM. Statins produce antiatherosclerotic effects in coronary heart disease patients Proceedings of the Romanian Academy 2001(in press).
Cited by
Sorted by citations
Items 101–200 of 910
Novel treatment strategies and drugs in development for cryptosporidiosis
Chavez, M. A., & White, A. C. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1500457 · Cited by 49
Microbial community modulates growth of symbiotic fungus required for stingless bee metamorphosis
Paludo, C. R., Pishchany, G., Andrade-Domínguez, A., da Silva-Junior, E. A., Menezes, C., do Nascimento, F. S., Currie, C. R., Kolter, R., Clardy, J., & Pupo, M. T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219696 · Cited by 49
Advantages and Disadvantages of Different Treatment Methods in Achondroplasia: A Review
Wrobel, W., Pach, E., & Beń‐Skowronek, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115573 · Cited by 53
Statins in Cancer Prevention and Therapy
Ricco, N., & Kron, S. J. (2023) · Cancers · doi:10.3390/cancers15153948 · Cited by 53
Human Validation of Genes Associated With a Murine Atherosclerotic Phenotype
Pasterkamp, G., van der Laan, S. W., Haitjema, S., Asl, H. F., Siemelink, M. A., Bezemer, T., van Setten, J., Dichgans, M., Malik, R., Worrall, B. B., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306958 · Cited by 49
Statins as anti‐tumor agents: A paradigm for repurposed drugs
Tripathi, S., Gupta, E., & Galande, S. (2024) · Cancer Reports · doi:10.1002/cnr2.2078 · Cited by 52
Statins Reduce Peri-procedural Complications in Carotid Stenting
Reiff, T., Amiri, H., Rohde, S., Hacke, W., & Ringleb, P. A. (2014) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2014.08.010 · Cited by 47
Wilkinson, E. L., Sidaway, J. E., & Cross, M. J. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26064 · Cited by 47
Neuroprotective effects of statins against amyloid β-induced neurotoxicity
Huang, C., Li, H., & Lin, C. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.226379 · Cited by 50
Harborg, S., Heide‐Jørgensen, U., Ahern, T. P., Ewertz, M., Cronin-Fenton, D. P., & Borgquist, S. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05749-5 · Cited by 47
Statin therapy is associated with aneurysm sac regression after endovascular aortic repair
Raux, M., Cochennec, F., & Becquemin, J. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.12.040 · Cited by 47
Statins—Their Role in Bone Tissue Metabolism and Local Applications with Different Carriers
Granat, M. M., Eifler-Zydel, J., & Kolmas, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042378 · Cited by 47
Peng, Y., Lin, C., Hsu, W., Chang, C., Yeh, H., Tung, C., Wu, Y.-L., Sung, F., & Kao, C. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12641 · Cited by 47
Tendinopathy and Tendon Rupture Associated with Statins
Deren, M. E., Klinge, S. A., Mukand, N. H., & Mukand, J. A. (2016) · JBJS Reviews · doi:10.2106/jbjs.rvw.15.00072 · Cited by 46
Alhazmi, H. A., Alnami, A., Arishi, M., Alameer, R., Bratty, M. A., Rehman, Z. U., Javed, S. A., & Arbab, I. A. (2017) · Scientia Pharmaceutica · doi:10.3390/scipharm86010001 · Cited by 47
Squalene monooxygenase - a target for hypercholesterolemic therapy
Belter, A., Skupińska, M., Giel-Pietraszuk, M., Grabarkiewicz, T., Rychlewski, L., & Barciszewski, J. (2011) · Biological Chemistry · doi:10.1515/bc.2011.195 · Cited by 50
Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease
Kayongo, A., Nyiro, B., Siddharthan, T., Kirenga, B., Checkley, W., Joloba, M. L., Ellner, J. J., & Salgame, P. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1146571 · Cited by 52
Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies
Taha, D. A., de Moor, C. H., Barrett, D. A., & Gershkovich, P. (2014) · Translational research · doi:10.1016/j.trsl.2014.01.013 · Cited by 45
Gupta, M., Sharma, R., & Kumar, A. (2019) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-019-00359-z · Cited by 45
Taha, N. M., Yousof, H.-A. S. A., El-Sayed, S. H., Younis, A. I., & Negm, M. S. (2017) · Experimental Parasitology · doi:10.1016/j.exppara.2017.07.010 · Cited by 44
Malik, M., Britten, J., Borahay, M. A., Segars, J. H., & Catherino, W. H. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.07.024 · Cited by 44
Yang, X., Jiang, X., Yan, W., Huang, Q., Sun, H., Zhang, X., Zhang, Z., Ye, W., Wu, Y., Govers, F., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.772994 · Cited by 42
A framework for identification of on- and off-target transcriptional responses to drug treatment
Huang, Y., Furuno, M., Arakawa, T., Takizawa, S., de Hoon, M., Suzuki, H., & Arner, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-54180-4 · Cited by 47
Lactobacillus mediates the expression of NPC1L1, CYP7A1, and ABCG5 genes to regulate cholesterol
Cao, K., Kai-ping, Z., Ma, M., Junjie, M., Tian, J., & Jin, Y. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2600 · Cited by 41
A Review on the Sources, Structures, and Pharmacological Activities of Lucidenic Acids
Zheng, C., Rangsinth, P., Shiu, P. H.-T., Wang, W., Li, R., Li, J., Kwan, Y. W., & Leung, G. (2023) · Molecules · doi:10.3390/molecules28041756 · Cited by 42
Romana, B., Batger, M., Prestidge, C. A., Colombo, G., & Sonvico, F. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140329232252 · Cited by 43
Rodríguez-Navarro, S., Raurell, I., Torres‐Arauz, M., García‐Lezana, T., Genescà, J., & Martell, M. (2017) · Scientific Reports · doi:10.1038/srep40461 · Cited by 42
Park, Y. H., Seo, S. Y., Lee, E., Ku, J. H., Kim, H. H., & Kwak, C. H. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.10.030 · Cited by 40
Comparative effects of high and low-dose simvastatin on prostate epithelial cells: The role of LDL
Murtola, T. J., Syvälä, H., Pennanen, P. T., Bläuer, M., Solakivi, T., Ylikomi, T. J., & Tammela, T. L. J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.022 · Cited by 41
Okoye, I., Namdar, A., Xu, L., Crux, N. B., & Elahi, S. (2017) · Oncotarget · doi:10.18632/oncotarget.21003 · Cited by 41
Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer
Garrido, M. P., Fredes, A. N., Lobos‐González, L., Valenzuela, M., Vera, D. B., & Romero, C. (2021) · Biomedicines · doi:10.3390/biomedicines10010077 · Cited by 42
Jain, P. G., & Surana, S. J. (2016) · EXCLI journal · doi:10.17179/excli2016-394 · Cited by 40
Gaitán‐Duarte, H., Álvarez, C., Rincón, C., González, N. Y., Cortés, J. A., Villar, J. C., Bravo-Ojeda, J. S., García-Peña, Á. A., Jaimes, W. A., Rodríguez, V., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101242 · Cited by 42
In vitro evaluation of the cholesterol-reducing ability of a potential probiotic Bacillus spp
Shobharani, P., & Halami, P. M. (2015) · Annals of Microbiology · doi:10.1007/s13213-015-1146-6 · Cited by 39
Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin
Laudi, S., Trump, S., Schmitz, V., West, J. D., McMurtry, I. F., Mutlak, H., Christians, U., Weimann, J., Kaisers, U., & Steudel, W. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00110.2006 · Cited by 39
Repurposing of statins via inhalation to treat lung inflammatory conditions
Bradbury, P., Traini, D., Ammit, A. J., Young, P. M., & Ong, H. X. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.005 · Cited by 38
Kang, M., Lee, K. H., Lee, H. S., Jeong, C. W., Ku, J. H., Kim, H. H., & Kwak, C. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184644 · Cited by 38
Targeting host lipid flows: Exploring new antiviral and antibiotic strategies
Fernández-Oliva, A., Ortega-González, P., & Risco, C. (2018) · Cellular Microbiology · doi:10.1111/cmi.12996 · Cited by 36
Accelerated Atherosclerosis in Rheumatoid Arthritis: Mechanisms and Treatment
Reiss, A. B., Silverman, A., Khalfan, M., Vernice, N. A., Kasselman, L. J., Carsons, S. E., & Leon, J. D. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190430113212 · Cited by 38
Guedes, L., Reis, P. B. P. S., Machuqueiro, M., Ressaissi, A., Pacheco, R., & Serralheiro, M. L. (2019) · Molecules · doi:10.3390/molecules24203795 · Cited by 44
Mannino, G., Iovino, P., Lauria, A., Genova, T., Asteggiano, A., Notarbartolo, M., Porcu, A., Serio, G., Chinigò, G., Occhipinti, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052664 · Cited by 40
Zubielienė, K., Valterytė, G., Jonaitienė, N., Žaliaduonytė, D., & Zabiela, V. (2022) · Medicina · doi:10.3390/medicina58111665 · Cited by 42
Roessler, J., Leistner, D. M., Landmesser, U., & Haghikia, A. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.08.018 · Cited by 39
Vallianou, I., & Hadzopoulou‐Cladaras, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147117 · Cited by 37
Bruder-Nascimento, T. B., Callera, G. E., Montezano, A. C. I., de Chantemèle, E. J. B., Tostes, R. C., & Touyz, R. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.01.043 · Cited by 37
Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders
Omeragic, A., Kayode, O., Hoque, M. T., & Bendayan, R. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00204-5 · Cited by 38
Simvastatin Loaded Dissolvable Microneedle Patches with Improved Pharmacokinetic Performance
Zulcaif, Zafar, N., Mahmood, A., Sarfraz, R. M., & Elaı̈ssari, A. (2022) · Micromachines · doi:10.3390/mi13081304 · Cited by 37
Chong, S. C., Dollah, M. A., Chong, P. P., & Maha, A. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.06.041 · Cited by 37
Viral modulation of lipid rafts and their potential as putative antiviral targets
Gee, Y. J., Sea, Y. L., & Lal, S. K. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2413 · Cited by 36
Probing Phase Transitions in Simvastatin with Terahertz Time-Domain Spectroscopy
Tan, N. Y. J., & Zeitler, J. A. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500649q · Cited by 36
Repurposing of Existing Statin Drugs for Treatment of Microbial Infections: How Much Promising?
Rana, R., Sharma, R., & Kumar, A. (2018) · Infectious Disorders - Drug Targets · doi:10.2174/1871526518666180806123230 · Cited by 36
for the SEMI-COVID-19 Network, Torres-Peña, J. D., Perez-Belmonte, L. M., Fuentes, F. J., Lopez-Carmona, M. D., Pérez‐Martínez, P., López‐Miranda, J., Carrasco-Sánchez, F. J., Vargas, J. A., Beamonte, E. D. C., et al. (2021) · Drugs · doi:10.1007/s40265-021-01498-x · Cited by 36
Atorvastatin facilitates chemotherapy effects in metastatic triple-negative breast cancer
Marti, J. L. G., Beckwitt, C. H., Clark, A. M., & Wells, A. H. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01529-0 · Cited by 38
Drexel, H. (2009) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00745.x · Cited by 33
Butyrate Lowers Cellular Cholesterol through HDAC Inhibition and Impaired SREBP-2 Signalling
Bridgeman, S. C., Woo, H. C., Newsholme, P., & Mamotte, C. D. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415506 · Cited by 41
Forbes, K. A., Shah, V. K., Siddals, K. W., Gibson, M., Aplin, J., & Westwood, M. (2014) · Molecular Human Reproduction · doi:10.1093/molehr/gau093 · Cited by 35
Screening and Molecular Characterization of Natural Fungal Isolates Producing Lovastatin
Upendra, R. S. (2013) · Journal of Microbial & Biochemical Technology · doi:10.4172/1948-5948.1000094 · Cited by 35
Becchetti, C., Dirchwolf, M., Schropp, J., Magini, G. M., Müllhaupt, B., Immer, F. F., Dufour, J., Banz, V. M., Berzigotti, A., Bosch, J., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17192 · Cited by 35
Antioxidant and hypolipidaemic properties of red seaweed, Gracilaria changii
Chan, P. T., Matanjun, P., Yasir, S. M., & Tan, T. S. (2013) · Journal of Applied Phycology · doi:10.1007/s10811-013-0135-z · Cited by 35
Reductive Dehydroxylation of Allyl Alcohols by IspH Protein
Gräwert, T., Span, I., Bacher, A., & Groll, M. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000833 · Cited by 35
Ballester, I., Daddaoua, A., López-Posadas, R., Nieto, A., Suárez, M. D., Zarzuelo, A., Martínez‐Augustin, O., & de Medina, F. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707227 · Cited by 34
Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes
Vieira, C. P., Fortmann, S. D., Hossain, M., Longhini, A. L. F., Hammer, S. S., Asare‐Bediako, B., Crossman, D. K., Sielski, M. S., Adu-Agyeiwaah, Y., Dupont, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137230 · Cited by 34
Werida, R. H., Khairat, I., & Khedr, N. F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111179 · Cited by 36
Groner, J., Göpferich, A. M., & Breunig, M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.034 · Cited by 34
Liu, Y., Liu, P., Song, Y., Li, S., Shi, Y., Quan, K., Guo, Y., Li, P., An, Q., & Zhu, W. P. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00867-8 · Cited by 34
Kowalska, K., Sabatowska, Z., Forycka, J., Młynarska, E., Franczyk, B., & Rysz, J. (2022) · Biomedicines · doi:10.3390/biomedicines10092320 · Cited by 35
Yoon, S. S., Dillon, C. F., Carroll, M. D., Illoh, K., & Ostchega, Y. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.5652 · Cited by 34
Targeted Degradation of PCSK9 In Vivo by Autophagy-Tethering Compounds
Ouyang, Z., Ma, M., Zhang, Z., Wu, H., Xue, Y., Jian, Y., Yin, K., Yu, S., Zhao, C., Guo, W., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01634 · Cited by 36
Lin, Y., Liu, J., Chong, S. Y., Ting, H. J., Tang, X., Yang, L., Zhang, S., Qi, X., Pei, P., Yi, Z., et al. (2024) · Small · doi:10.1002/smll.202401659 · Cited by 32
Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter
Maideen, N. M. P., Gobinath, M., & Balasubramanian, K. (2018) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818767220 · Cited by 33
SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability
Zubiaur, P., Benedicto, M. D., Villapalos‐García, G., Navares‐Gómez, M., Mejía-Abril, G. P., Román, M. C., Martín‐Vílchez, S., Ochoa, D., & Abad‐Santos, F. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030204 · Cited by 33
Possible mechanisms of cholesterol elevation aggravating COVID-19
Tang, Y., Hu, L., Liu, Y., Zhou, B., Qin, X., Ye, J., Shen, M., Wu, Z., & Zhang, P. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.62021 · Cited by 33
Crosstalk between Statins and Cancer Prevention and Therapy: An Update
Grabarek, B. O., Boroń, D., Morawiec, E., Michalski, P., Palazzo-Michalska, V., Pach, Ł., Dziuk, B., Świder, M., & Zmarzły, N. (2021) · Pharmaceuticals · doi:10.3390/ph14121220 · Cited by 34
Pathways and Molecular Mechanisms Governing LDL Receptor Regulation
Schmidt, H. M., Jarrett, K. E., de Aguiar Vallim, T. Q., & Tarling, E. J. (2025) · Circulation Research · doi:10.1161/circresaha.124.323578 · Cited by 33
Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?
Tsioulos, G., Kounatidis, D. C., Vallianou, N. G., Poulaki, A., Kotsi, E., Christodoulatos, G. S., Tsilingiris, D., Karampela, Ι., Skourtis, A., & Dalamaga, Μ. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063537 · Cited by 36
Diabetic Cardiomyopathy—From Basics through Diagnosis to Treatment
Radzioch, E., Dąbek, B., Balcerczyk-Lis, M., Frąk, W., Fularski, P., Młynarska, E., Rysz, J., & Franczyk, B. (2024) · Biomedicines · doi:10.3390/biomedicines12040765 · Cited by 35
The good and bad effects of statins on insulin sensitivity and secretion
Muscogiuri, G., Sarno, G., Gastaldelli, A., Savastano, S., Ascione, A., Colao, A., & Orio, F. (2014) · Endocrine Research · doi:10.3109/07435800.2014.952018 · Cited by 32
Effect of Statins on Renal Function in Chronic Kidney Disease Patients
Hu, P., Wu, M., Lin, T.-C., Chen, T.-T., Wu, Y., Su, S., Lu, K., Chen, J.-S., Sung, F.-C., Lee, C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34632-z · Cited by 32
Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer
Ricco, N., Flor, A. C., Wolfgeher, D., Efimova, E. V., Ramamurthy, A., Appelbe, O. K., Brinkman, J. A., Truman, A. W., Spiotto, M. T., & Kron, S. J. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12535 · Cited by 32
Awan, Z. A., Fahmy, U. A., Badr-Eldin, S. M., Ibrahim, T. S., Asfour, H. Z., Al-Rabia, M. W., Alfarsi, A., Alhakamy, N. A., Abdulaal, W. H., Sadoun, H. A., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070597 · Cited by 32
RetractedNew Addition to the Statin’s Effect
Klçcoǧlu, S. S., & Erdemlı, E. (2007) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000240974.07999.bc · Cited by 32
Lipoprotein(a) in clinical practice: New perspectives from basic and translational science
Scipione, C. A., Koschinsky, M. L., & Boffa, M. B. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1415866 · Cited by 34
Biological consequences of statins in Candida species and possible implications for human health
Wikhe, K., Westermeyer, C., & Macreadie, I. G. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351529 · Cited by 31
Pharma[e]cology: How the Gut Microbiome Contributes to Variations in Drug Response
Trepka, K. R., Olson, C. A., Upadhyay, V., Zhang, C., & Turnbaugh, P. J. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-022724-100847 · Cited by 35
Statins in Asthma: Potential Beneficial Effects and Limitations
Bhattacharjee, D., Chogtu, B., & Magazine, R. (2015) · Pulmonary Medicine · doi:10.1155/2015/835204 · Cited by 31
Pharmacological Options in Atherosclerosis: A Review of the Existing Evidence
Gupta, K. K., Ali, S., & Sanghera, R. S. (2018) · Cardiology and Therapy · doi:10.1007/s40119-018-0123-0 · Cited by 35
Antiviral Potential of Natural Resources against Influenza Virus Infections
Eichberg, J., Maiworm, E., Oberpaul, M., Czudai-Matwich, V., Lüddecke, T., Vilcinskas, A., & Hardes, K. (2022) · Viruses · doi:10.3390/v14112452 · Cited by 31
Machaba, K. E., Cobongela, S. Z. Z., Mosa, R. A., Oladipupo, L. A., Djarova, T. G., & Opoku, A. R. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-131 · Cited by 31
Durkar, A. M., Patil, R. R., & Suresh Ramnath, N. A. I. K. (2014) · PubMed · Cited by 30
Mellal, A. A., Hussain, N., & Said, A. S. A. (2019) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s214938 · Cited by 34
Kumar, S., Srivastava, N., & Gomes, J. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.12.014 · Cited by 30
High‐Density Lipoprotein Cholesterol Concentration and Acute Kidney Injury After Cardiac Surgery
Smith, L. E., Smith, D. K., Blume, J. D., Linton, M. F., & Billings, F. T. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006975 · Cited by 30
Inhibitory Effects of Procyanidin B2 Dimer on Lipid-laden Macrophage Formation
Chen, D., Cai, X., Kwik-Uribe, C. L., Zeng, R., & Zhu, X. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000242052.60502.21 · Cited by 29
LRRK2 and Lipid Pathways: Implications for Parkinson’s Disease
Galper, J., Kim, W. S., & Dzamko, N. L. (2022) · Biomolecules · doi:10.3390/biom12111597 · Cited by 29
Guan, Y., Xie, C., Zhang, R., Zhang, Z., Tian, Z., Feng, J., Shen, X., Li, H., Chang, S., Zhao, C., et al. (2023) · Food & Function · doi:10.1039/d3fo01308a · Cited by 32
Cholesterol suppresses antimicrobial effect of statins.
Haeri, M. R., White, K., Qharebeglou, M., & Ansar, M. M. (2015) · PubMed Central · Cited by 29
Badr-Eldin, S. M., Alhakamy, N. A., Fahmy, U. A., Ahmed, O. A. A., Asfour, H. Z., Althagafi, A. A., Aldawsari, H. M., Rizg, W. Y., Mahdi, W. A., Alghaith, A. F., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.642171 · Cited by 29
New and emerging lipid-modifying drugs to lower LDL cholesterol
Kosmas, C. E., Pantou, D., Sourlas, A., Papakonstantinou, E. J., Uceta, R. E., & Guzman, E. (2021) · Drugs in Context · doi:10.7573/dic.2021-8-3 · Cited by 32
Pleiotropic properties of statins via angiogenesis modulation in cardiovascular disease
Zahedipour, F., Butler, A. E., Eid, A. H., & Sahebkar, A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.07.010 · Cited by 28
Therapeutic effects of statins on osteoarthritis: A review
Saberianpour, S., Abolbashari, S., Modaghegh, M. H. S., Karimian, M. S., Eid, A. H., Sathyapalan, T., & Sahebkar, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30309 · Cited by 29
Metadata
- Authors
- Stancu, C., & Sima, A.
- Affiliations
- Romanian Academy (RO)
- Corresponding author
- Sima, Anca
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2001-10
- Volume
- 5
- Issue
- 4
- Pages
- 378-387
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- PMC
- PMC6740083
- OpenAlex
- W2006572302
- Cited by
- 911
- References
- 42
- Citations by year
- 2026: 35 · 2025: 65 · 2024: 73 · 2023: 81 · 2022: 90 · 2021: 94 · 2020: 96 · 2019: 66 · 2018: 51 · 2017: 48 · 2016: 35 · 2015: 25 · 2014: 34 · 2013: 22 · 2012: 18
- FWCI
- 0.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Cellular and Molecular Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- statins, HMG-CoA reductase inhibition, cholesterol biosynthesis, lipid metabolism, LDL cholesterol, atherosclerosis, mevalonate metabolism, terpenoids, pleiotropy, coronary events, bone formation, tumor cell proliferation, primary and secondary prevention
- MeSH terms
- Cholesterol Esters, Endothelium, Vascular, Humans, Hypercholesterolemia, Liver, Models, Biological, Muscle, Smooth, Vascular, Molecular Structure, Signal Transduction, Platelet Activation, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review